(Q44451380)
Statements
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders (English)
Eugene R Schiff
Selim Karayalcin
Robert P Perrillo
R A de Man
Zachary Goodman
Lynn D Condreay
Lynn M Crowther
Mary A Woessner
Penny J McPhillips
Nathaniel A Brown
International Lamivudine Investigator Group